Joseph M Connors

发表

State-of-the-art therapeutics: Hodgkin's lymphoma.

J. Connors, Joseph M Connors, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.

Scott E Smith, Bruce D Cheson, Andreas Engert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Karey Shumansky, Randy D Gascoyne, John J Spinelli, 2005, Blood.

Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study

Ali Bashashati, Robert Kridel, Ahmet Dogan, 2016, PLoS medicine.

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Robert Kridel, Donna Neuberg, Alessandro Pastore, 2015, The Lancet. Oncology.

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Kai Fu, Raymond R Tubbs, Jan Delabie, 2014, Blood.

Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma

Steven J. M. Jones, Christian Steidl, Dipankar Sen, 2018, Nature Communications.

Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)

Mehdi Najafzadeh, Carlo A Marra, Marco A Marra, 2013, BMC Health Services Research.

Molecular diagnosis of Burkitt's lymphoma.

Richard Simon, Kai Fu, Jan Delabie, 2006, The New England journal of medicine.

The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation.

Randy D Gascoyne, Richard Klasa, R. Gascoyne, 2010, Blood.

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.

Kajia Cao, Quiming Zhu, Javeed Iqbal, 2004, The American journal of pathology.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

Jian Su, Wen Tan, Paolo Vineis, 2015, Journal of the National Cancer Institute.

Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas

Mattias Höglund, Reiner Siebert, Randy D Gascoyne, 2004, Genes, chromosomes & cancer.

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.

Ryan R Brinkman, Ali Bashashati, Angela Brooks-Wilson, 2009, Blood.

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Randy D Gascoyne, Laurie H Sehn, R. Gascoyne, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma

Roland Schmitz, Bao Tran, Yongmei Zhao, 2018, The New England journal of medicine.

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

Adrian Wiestner, Hui Liu, Kazutaka Nakayama, 2007, Blood.

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

Jan Delabie, Randy D Gascoyne, Weihong Xu, 2008, Science.

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Paolo Vineis, Theodore R Holford, Peter Kraft, 2016, Nature Communications.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Steven J. M. Jones, Christian Steidl, Javeed Iqbal, 2010, The New England journal of medicine.

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Stefano A Pileri, Lisa Rimsza, Randy D Gascoyne, 2008, Blood.

John M Bennett, J. Armitage, J. Connors, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma

Jan Delabie, Randy D Gascoyne, Andreas Rosenwald, 2007, Genes, chromosomes & cancer.

Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients

Yongjun Zhao, Martin Krzywinski, Christian Steidl, 2015, Genome Biology.

Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

Randy D Gascoyne, John J Spinelli, Richard P Gallagher, 2009, BMC Medical Genetics.

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.

Christian Steidl, Raymond T Ng, Sohrab P Shah, 2009, Blood.

Revised response criteria for malignant lymphoma.

Sigrid Stroobants, Bruce D Cheson, Lena Specht, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.

Robert Tibshirani, Yasodha Natkunam, Arnon Nagler, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cooperative epigenetic modulation by cancer amplicon genes.

Christian Steidl, Peter Möller, Jan Delabie, 2010, Cancer cell.